WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Stock Ownership - Who owns Merck & Co?

Insider buying vs selling

Have Merck & Co Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph RomanelliPresident Human Health Intl2023-02-155,000$108.22
$541.10kSell
Steven MizellEVP Chief HR Officer2023-02-131,815$109.10
$198.02kSell
David Michael WilliamsEVPChief InfoDigital Officer2023-02-10413$106.72
$44.08kSell
David Michael WilliamsEVPChief InfoDigital Officer2023-02-101,205$106.72
$128.60kBuy
Steven MizellEVP Chief HR Officer2023-02-095,000$107.00
$535.01kSell
Steven MizellEVP Chief HR Officer2023-02-064,436$104.26
$462.48kSell
Jennifer ZacharyEVP General Counsel2023-02-0375,436$103.17
$7.78MSell
Jennifer ZacharyEVP General Counsel2023-02-0375,436$56.04
$4.23MBuy
Robert M. DavisCEO President2023-01-2324,224$109.88
$2.66MBuy
Steven MizellEVP Chief HR Officer2023-01-2312,192$109.88
$1.34MBuy

1 of 11

MRK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRK insiders and whales buy or sell their stock.

MRK Shareholders

What type of owners hold Merck & Co Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.95%227,205,978$24.07BInstitution
Blackrock Inc8.46%214,731,385$22.74BInstitution
State Street Corp4.65%117,961,857$12.49BInstitution
Wellington Management Group LLP2.44%62,016,871$6.57BInstitution
Geode Capital Management LLC1.90%48,339,275$5.12BInstitution
Morgan Stanley1.65%41,850,081$4.43BInstitution
Bank Of America Corp1.58%40,200,217$4.26BInstitution
Bank Of New York Mellon Corp1.20%30,395,629$3.22BInstitution
Northern Trust Corp1.19%30,213,883$3.20BInstitution
Charles Schwab Investment Management Inc1.18%29,977,649$3.18BInstitution

1 of 3

MRK vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRK74.90%0.19%Net SellingNet Buying
ABBV69.75%0.15%Net SellingNet Selling
PFE69.28%0.27%Net BuyingNet Selling
AZN32.79%0.00%
LLY82.89%11.57%Net SellingNet Selling

Merck & Co Stock Ownership FAQ

Who owns Merck & Co?

Merck & Co (NYSE: MRK) is owned by 74.90% institutional shareholders, 0.19% Merck & Co insiders, and 24.91% retail investors. Vanguard Group Inc is the largest individual Merck & Co shareholder, owning 227.21M shares representing 8.95% of the company. Vanguard Group Inc's Merck & Co shares are currently valued at $24.17B.

If you're new to stock investing, here's how to buy Merck & Co stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.